Company profile: Capricor
1.1 - Company Overview
Company description
- Provider of cell and exosome-based therapeutics, including CAP-1002, an allogeneic cardiosphere-derived cell therapy in Phase 3 for Duchenne muscular dystrophy; the StealthX exosome platform for designer protein surface expression, cargo loading and targeted delivery to enable precision therapeutics and vaccines; and an exosome-based multivalent SARS-CoV-2 vaccine under development with the NIH.
Products and services
- CAP-1002: Engineers an allogeneic, Phase 3 cell therapy for Duchenne muscular dystrophy using cardiosphere-derived cells that mediate immunomodulatory, anti-inflammatory, and anti-fibrotic effects
- Exosome-based multivalent vaccine: Constructs an exosome-based vaccine under development with the NIH for SARS-CoV-2 prevention, utilizing Capricor's StealthX platform for targeted delivery
- StealthX platform: Delivers a proprietary exosome technology enabling designer protein surface expression, cargo loading, and targeted delivery to architect precision therapeutics and vaccines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Capricor
Cardialen
HQ: United States
Website
- Description: Provider of pain-free cardioversion therapies for atrial fibrillation, developing implantable low-energy (low voltage) atrial cardioverters to address major unmet needs of this condition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardialen company profile →
Rapidscan Pharma
HQ: United States
Website
- Description: Provider of regadenoson, a pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease, with licensed rights to sell in Europe and select territories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rapidscan Pharma company profile →
Crux Biomedical
HQ: United States
Website
- Description: Provider of biotech solutions addressing the clinical limitations of current vena cava filters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crux Biomedical company profile →
AUM Cardiovascular
HQ: United States
Website
- Description: Provider of medical device manufacturing solutions specializing in the biotechnology, medical, and healthcare fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AUM Cardiovascular company profile →
Spectrum Dynamics Medical
HQ: United States
Website
- Description: Provider of innovative high definition functional imaging technology that delivers high-speed, high-resolution nuclear images in compact systems designed to meet clinical and workflow demands, including BroadView™ Technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectrum Dynamics Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Capricor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Capricor
2.2 - Growth funds investing in similar companies to Capricor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Capricor
4.2 - Public trading comparable groups for Capricor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →